arrow_back Back to App

Study on Hair Straighteners and Uterine Cancer Link

This act mandates a study on the relationship between chemical hair straighteners and uterine cancer, with a focus on women of color. The goal is to assess product safety and potentially impose additional testing requirements on manufacturers. The study's findings could influence future regulations on hair styling products.
Key points
Mandates a study on the link between chemical hair straighteners and uterine cancer.
Focuses on the increased incidence of uterine cancer among women of color.
Evaluates whether the FDA should impose additional testing requirements on straightener manufacturers.
Study results to be reported to Congress within two years.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_S_2285
Sponsor: Sen. Blunt Rochester, Lisa [D-DE]
Process start date: 2025-07-15
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Uterine Cancer Study Act of 2025

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_S_2285.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2025-07-15.

What are the main provisions?

Key points include:

  • Mandates a study on the link between chemical hair straighteners and uterine cancer.
  • Focuses on the increased incidence of uterine cancer among women of color.
  • Evaluates whether the FDA should impose additional testing requirements on straightener manufacturers.
  • Study results to be reported to Congress within two years.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Blunt Rochester, Lisa [D-DE].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health